The expression of CX3CL1 and CXCL16 was confirmed on protein level by immunocytochemistry (lower panel of Figure 1), which revealed high expression for the brain tumor cell lines and low expression for the breast carcinoma cell line MCF-7. The gene discussed is CXCL16; the disease is brain neoplasm.